Results of a clinical trial that began in 2001 show that a gene therapy cocktail conveyed into the brain by a molecular special delivery vehicle may help extend the lives of children with Canavan disease, a rare and fatal neurodegenerative disorder.

The rest is here:

Gene Therapy Cocktail Shows Promise in Long-Term Clinical Trial for Rare Fatal Brain Disorder